HPM Partners »

Iovance Biotherapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $398k 96k 4.16
2026-03-31 $68k 19k 3.51

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Two Sigma Investments
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Susquehanna International
Dimensional Fund Advisors
Morgan Stanley
Jane Street
Palo Alto Investors
Goldman Sachs Group
Nuveen

View all funds holding Iovance Biotherapeutics